Argonaut, as Lead Manager has successfully raised A$8 million for OpenDNA Limited (ASX: OPN) (“OpenDNA” or “the Company”) via an oversubscribed initial public offering (“IPO”) of 40 million new fully paid ordinary shares at $0.20 per share. Proceeds of the IPO funds raised will be used to fully commercialise OpenDNA’s proven personalisation technology and accelerate business development, sales & marketing efforts. OpenDNA technology can be used by businesses regardless of size, industry and operating platform.
Argonaut | The Natural Choice in Resources.
© 2024 Argonaut.